Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

11th Annual Manhattan Film Festival Set To Open With World Premiere of The Pathological Optimist
  • USA - English


News provided by

The Media Model: Brand Strategy & Public Relations

Mar 02, 2017, 03:00 ET

Share this article

Share toX

Share this article

Share toX

New York, NY (PRWEB) March 02, 2017 -- Manhattan Film Festival announced that The Pathological Optimist by Director Miranda Bailey, has been selected to open the 11th annual series on April 20, 2017. The documentary is a character study that features never-before-seen, full access footage, of the man at the center of one of the biggest medical and media controversies of our time – Andrew Wakefield – whose film Vaxxed: From Cover-Up to Catastrophe, screened at last year’s Manhattan Film Festival and sparked fierce debate.

“As a filmmaker, I was drawn to exploring a controversial subject so I’m grateful that the Manhattan Film Festival embraces provocative films, and I look forward to premiering The Pathological Optimist, says Director Miranda Bailey.

The screening will also include a filmmaker Q & A with participants in the film to create an open discussion about the subject matter.

“MFF strongly feels part of the role for an independent film festival is to spark debate and give filmmakers a platform,” said Festival Director Philip Nelson. “We are thrilled and honored to open the festival with The Pathological Optimist, and look forward to the dialog to follow.”

Bailey made her directorial debut with the documentary Greenlit – a humorous documentary examining the hypocrisy inherent in Hollywood’s “green” movement - premiered at the 2010 SXSW Film Festival to critical acclaim and was acquired by IFC International. Additionally, she established herself as a prolific producer championing independent films as CEO of Cold Iron Pictures. In the last year, her film Swiss Army Man and Don’t Think Twice were released to box office success and critical acclaim. Her most recent film, Norman, will be released by Sony Classics April 14.

A complete lineup of films will be announced March 8th. The 11th annual Manhattan Film Festival will take place April 19-30, 2017. For more information on the Manhattan Film Festival, visit http://manhattanff.com/

Social Media: Facebook @manhattanfilmfestival | Twitter @ManhattanFF

Opening Night Festival Media and Q&A Segment Inquiries: Alvin Woods, The Media Model. E: alvin(at)themediamodel(dot)com

Opening Night Film and Director Interview Inquiries: Hilda Somarriba, Prism Media Group. E: hilda(at)prism-mg(dot)com

About Manhattan Film Festival (MFF):
MFF was founded by independent filmmakers that learned first-hand how hard it is to find an independent film an audience. For more than a decade we have worked to program a diverse film lineup that features student, emerging, and established filmmakers. Each year MFF honors three filmmakers with a Film Heals Award. This award recognizes filmmakers that use the power of film to promote peace, justice, equality, and humanity.

Our widely popular Filmmaker Revenue Sharing Program generates thousands of dollars for independent filmmakers. This program allows filmmakers the opportunity to earn 50% of each ticket sold. Participants will be given an affiliate account where they can track sales in real time. This year we are launching our Filmmaker Advisory Program. This program will feature customized mentoring sessions for filmmakers.

About THE PATHOLOGICAL OPTIMIST:
The PATHOLOGICAL OPTIMIST takes us into the inner sanctum of Andrew Wakefield – the subject at the center of the recent Tribeca Film Festival scandal surrounding his film VAXXED: From Cover-up to Controversy – discredited and stripped of his medical license for his infamous study suggesting a link between the MMR vaccine, bowel disease, and autism. The film chronicles Wakefield and his family from 2011- 2016 as he fights for his day in court in a little-known defamation case against the British Medical Journal. Wakefield attempts to clear his name as the media-appointed Father of the Anti-vaccine movement. Director Miranda Bailey weaves a delicate portrait of a man who is THE PATHOLOGICAL OPTIMIST utilizing a never-before-seen, full access look at the man at the center of one of the biggest medical and media controversies of our times.

Alvin Woods, The Media Model: Brand Strategy & Public Relations, http://www.themediamodel.com/, +1 (347) 949-8172, [email protected]

Modal title

The Pathological Optimist - Premieres Opening Night at Manhattan Film Festival 2017
The Pathological Optimist - Premieres Opening Night at Manhattan Film Festival 2017
Manhattan Film Festival - April 19–30, 2017
Manhattan Film Festival - April 19–30, 2017
The Pathological Optimist - Premieres Opening Night at Manhattan Film Festival 2017 Manhattan Film Festival - April 19–30, 2017

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.